Identification of a phosphodiester hexanucleotide that inhibits HIV-1 infection in vitro on covalent linkage of its 5'-end with a dimethoxytrityl residue

被引:13
作者
Furukawa, H
Momota, K
Agatsuma, T
Yamamoto, I
Kimura, S
Shimada, K
机构
[1] UNIV TOKYO,FAC MED,TOKYO 113,JAPAN
[2] TOKYO SENBAI HOSP,TOKYO,JAPAN
来源
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 1997年 / 7卷 / 03期
关键词
D O I
10.1089/oli.1.1997.7.167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been shown in previous reports that a guanine-rich phosphodiester oligonucleotide bearing a dimethoxytrityl (DmTr) residue on its 5'-terminal, DmTr-TGGGAGGTGGGTCTG (SA-1042), is an inhibitor of HIV-1 infection in vitro, SA-1042 interfered with the attachment of gp120 to the CD4 receptor and the subsequent entry stage of viral infection, We investigated the structure-activity relationship of the DmTr-conjugated oligomer by using 15-mer oligonucleotides with various nucleotide sequences. Results show that location of guanine nucleosides at the 5'-terminal and modification of the 5'-terminal with DmTr are essential for anti-HIV-1 activity, First, substitution of the guanine nucleoside close to the 5'-terminal of SA-1042 with another nucleotide prevented antiviral activity. Second, the existence of at least three consecutive guanine nucleosides adjacent to the 5'-terminal was required for the activity, Finally, modification of the 5'-terminal was essential for the activity, Based on these findings, the hexanucleotide, DmTr-TGGGAG, was identified as a potent inhibitor of HIV-1 infection, The hexamer was found to be capable of inhibiting the binding of gp120 to its receptor CD4 molecule, and it was also capable of inhibiting accessibility of anti-V3 monoclonal antibody to its ligand V3 peptide.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 15 条
[1]  
AGATSUMA T, 1996, ANTIVIR RES, V50, P138
[2]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[3]   IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GENE-SEQUENCES INFLUENCING VIRAL ENTRY INTO CD4-POSITIVE HELA-CELLS, T-LEUKEMIA CELLS, AND MACROPHAGES [J].
CHESEBRO, B ;
NISHIO, J ;
PERRYMAN, S ;
CANN, A ;
OBRIEN, W ;
CHEN, ISY ;
WEHRLY, K .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5782-5789
[4]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[5]   MECHANISM OF INHIBITION OF HIV-1 INFECTION IN-VITRO BY GUANINE-RICH OLIGONUCLEOTIDES MODIFIED AT THE 5' TERMINAL BY DIMETHOXYTRITYL RESIDUE [J].
FURUKAWA, H ;
MOMOTA, K ;
AGATSUMA, T ;
YAMAMOTO, I ;
KIMURA, S ;
SHIMADA, K .
NUCLEIC ACIDS RESEARCH, 1994, 22 (25) :5621-5627
[6]   FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS [J].
GALLO, RC ;
SALAHUDDIN, SZ ;
POPOVIC, M ;
SHEARER, GM ;
KAPLAN, M ;
HAYNES, BF ;
PALKER, TJ ;
REDFIELD, R ;
OLESKE, J ;
SAFAI, B ;
WHITE, G ;
FOSTER, P ;
MARKHAM, PD .
SCIENCE, 1984, 224 (4648) :500-503
[7]   BIOLOGICALLY-ACTIVE OLIGODEOXYRIBONUCLEOTIDES .2. STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANTI-HIV-1 PENTADECADEOXYRIBONUCLEOTIDES BEARING 5'-END-MODIFICATIONS [J].
HOTODA, H ;
MOMOTA, K ;
FURUKAWA, H ;
KANEKO, M ;
NAKAMURA, T ;
KIMURA, S ;
SHIMADA, K .
NUCLEOSIDES & NUCLEOTIDES, 1994, 13 (6-7) :1375-1395
[8]   LYMPHOCYTE-T T4 MOLECULE BEHAVES AS THE RECEPTOR FOR HUMAN RETROVIRUS LAV [J].
KLATZMANN, D ;
CHAMPAGNE, E ;
CHAMARET, S ;
GRUEST, J ;
GUETARD, D ;
HERCEND, T ;
GLUCKMAN, JC ;
MONTAGNIER, L .
NATURE, 1984, 312 (5996) :767-768
[9]   INDUCTION OF CD4-DEPENDENT CELL-FUSION BY THE HTLV-III/LAV ENVELOPE GLYCOPROTEIN [J].
LIFSON, JD ;
FEINBERG, MB ;
REYES, GR ;
RABIN, L ;
BANAPOUR, B ;
CHAKRABARTI, S ;
MOSS, B ;
WONGSTAAL, F ;
STEIMER, KS ;
ENGLEMAN, EG .
NATURE, 1986, 323 (6090) :725-728
[10]  
OJWANG J, 1994, J ACQ IMMUN DEF SYND, V7, P560